Cartilage development is initiated by the differentiation of mesenchymal cells into chondrocytes.
INTRODUCTION
Cartilage formation during embryo development is initiated by the differentiation of mesenchymal cells into chondrocytes. Chondrogenesis is triggered by precartilage condensation (i.e., aggregation of mesenchymal cells) that develops into cartilage nodules. Chondrocytes in cartilage either further mature into hypertrophic chondrocytes during endochondral bone formation or remain as permanent chondrocytes throughout their lifecycle in joint articular cartilage. Articular chondrocytes synthesize cartilage-specific extracellular matrix components, such as type II collagen and sulfated proteoglycan, to maintain cartilage homeostasis (1) (2) (3) .
Homeostasis is destroyed during joint cartilage diseases, such as rheumatoid arthritis and osteoarthritis, eventually leading to cartilage destruction, which involves activation of matrix metalloproteinases, loss of differentiated chondrocyte phenotypes (i.e. dedifferentiation) and increase in chondrocyte apoptosis (4, 5) .
Differentiation, survival and maintenance of differentiated chondrocyte phenotype are regulated by a number of physical and soluble factors. For example, chondrogenesis of mesenchymal cells during limb bud development is regulated by cell-to-cell adhesion, cell-to-cell matrix interactions and a complicated array of growth factors, including bone morphogenetic protein, fibroblast growth factor, epidermal growth factor, insulin -like growth factor (IGF) -1, parathyroid hormone-related peptide and Indian hedgehog (1) . Survival and the number of cells displaying fragmented DNA. Briefly, cells were fixed in 80% ethanol and incubated for 1 h with 50 µg/ml propidium iodide, 0.1% Nonidet P-40, and 100 µg/ml RNase A in PBS. The number of cells containing fragmented DNA was quantified on a FACSort flow cytometer with the Cellquest analysis program, using approximately 1 × 10 4 cells (Becton Dickinson, CA).
PI3-kinase assay -Chondrifying mesenchymal cells or primary culture articular chondrocytes were lysed in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 1 mM EGTA, 1%
Triton X-100, 10% glycerol, protease inhibitors (1 mM phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml pepstatin A, 1 mM 4-(2-aminoethyl) benzene-sulfonyl fluoride) and phosphotase inhibitors (1 mM sodium orthovanadate and 25 mM NaF). Following removal of cell debris by centrifugation at 4°C for 10 min at 13,000 g, equal amounts of protein (500 µg) were incubated overnight with antiphosphotyrosine antibody (Transduction Laboratories, Lexington, KY) and collected on protein A-sepharose.
Immune complexes were washed three times with PBS containing 1% NP-40, three times with buffer containing 100 mM Tris-HCl (pH 7.5) and 500 mM LiCl 2, and twice with buffer containing 25 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 1 mM EDTA. Next, immune complexes were resuspended in 45 µl kinase assay buffer (20 mM Tris-HCl, pH 7.6, 75 mM NaCl, 10 mM MgCl 2 , 1 mM EGTA), and the kinase reaction was initiated by adding 200 µg/ml phosphatidylinositol and [γ-cleave d synthetic substrate of caspase-3, Ac-Asp-Glu-Val-Asp-chromophore p-nitroaniline, as described previously (9) . Chondrocytes were lysed in the buffer provided in a colorimetric assay kit (Clontech). Lysates (100 µg protein) were reacted with 50 µM Ac-Asp-Glu-Val-Asp-chromophore p-nitroaniline in reaction buffer (0.1 M Hepes, pH 7.4, 20% glycerol, 10 mM dithiothreitol and protease inhibitors, as described above) for 1 h at 37 o C and analyzed in an ELISA reader. Enzyme activity was calculated from a standard curve prepared using p- (Fig. 1A) , indicating chondrogenic
differentiation. An in vitro kinase assay (Fig. 1B) showed that in the absence of serum, IGF -1 activated PI3-kinase and its downstream signaling molecule, Akt (demonstrated by increased phosphorylation) ( Fig. 1 C, upper panel). IGF-1 effects on Akt activation were dose-dependent ( 
IGF -1 induces chondrogenesis by modulating PKC, ERK, and p38 kinase signaling via PI3-kinase -We
previously showed that serum-induced chondrogenesis requires increased expression and activity of PKCα, which is necessary for ERK inhibition (13) . Additionally, PKCα-independent activation of p38 kinase is a prerequisite for chondrogenesis (14) . Accordingly, we examined whether IGF-1 induces chondrogenesis via a PI3-kinase pathway by modulating PKCα, ERK and/or p38 kinase. PKCα expression and activity were increased during IGF-1-induced chondrogenic differentiation of mesenchymal cells ( We next examined whether ERK and p38 kinase mediate IGF-1-induced chondrogenesis, based on the finding that these two proteins oppositely regulate chondrogenesis of mesenchymal cells (14) . During micromass culture of mesenchymal cells in the absence of IGF -1, ERK-1 phosphorylation levels were high at day 1, and dramatically decreased thereafter. ERK-1 phosphorylation was significantly reduced upon the addition of IGF-1 (Fig. 4A, upper panel) . In contrast, p38 kinase activity remained low during control micromass culture, but was significantly increased upon IGF-1 treatment (Fig. 4A, upper panel) . ERK inhibition and p38 kinase activation by IGF-1 were dose-dependent (Fig. 4A, middle panel) . Moreover, IGF-1 effects were abolished by LY294002 treatment (Fig. 4A, lower panel) . The ERK inhibitor, PD98059 , potentiated IGF-1-induced chondrogenesis of mesenchymal cells, whereas the p38 kinase inhibitor, SB203580, blocked chondrogenesis (Fig. 4B) . The above results are consistent with the hypothesis that IGF-1 induces chondrogenic differentiation of mesenchymal cells by activating p38 kinase and inhibiting ERK-1 via a PI3-kinase pathway. and 5B). In addition, NO production induced apoptosis of articular chondrocytes that was blocked by the addition of 100 ng/ml IGF-1 (Fig. 5C ). Our data strongly imply that the growth factor inhibits both NO-induced dedifferentiation and apoptosis. As chondrocyte responses in monolayer culture may differ from those in a three-dimensional natural matrix, the effects of NO and IGF-1 on apoptosis and dedifferentiation of chondrocytes were examined during cartilage explant culture.
IGF -1 inhibits NO-induced de differentiation and apoptosis of articular chondrocytes -
Immunocytochemistry analyses and TUNEL assay revealed that IGF-1 blocked NO-induced inhibition of type II collagen synthesis and apoptotic cell death, respectively, similar to the effects on chondrocytes cultured on plastic (Fig. 6) . Thus, IGF-1 blocks NO-induced dedifferentiation and apoptosis of articular chondrocytes cultured either on plastic or in three-dimensional natural matrix.
IGF-1 blocks NO-induced dedifferentiation and apoptosis of chondrocytes via a PI3-kinase pathway -
The roles of PI3-kinase and Akt in NO-induced apoptosis and dedifferentiation, and the effects of IGF-1 were examined in articular chondrocytes. NO decreased PI3-kinase activity, as determined by an in vitro kinase assay (Fig. 7 A, lower panel) . The phosphorylation status and reduced total Akt protein levels indicate that NO production additionally inhibits Akt activity (Fig. 7A, upper panel) . In the absence of NO, IGF-1 transiently activated both PI3-kinase and Akt without modulation of Akt protein levels (Fig. 7B) . The decrease in PI3-kinase and Akt activities caused by NO production was abolished upon treatment of chondrocytes with IGF-1 by guest on October 1, 2017
http://www.jbc.org/ Downloaded from (Fig. 7 C) . The specific roles of PI3-kinase and Akt during IGF-1 modulation of NO-induced dedifferentiation and apoptosis of chondrocytes were examined by inhibiting PI3-kinase with LY294002, prior to NO production and IGF-1 treatment. As shown in Fig. 8A , LY294002 abolished the effects of IGF-1 on phosphorylation and expression of Akt, type II collagen expression (Fig. 8A) , proteoglycan synthesis (Fig. 8B) , and apoptosis of chondrocytes (Fig. 8C) . These results collectively suggest that NO induces downregulation of PI3-kinase and Akt signaling, and that IGF-1 inhibits dedifferentiation and apoptosis by blocking NO-induced inhibition of the PI3-kinase and Akt signaling pathways.
IGF -1 blocks NO-induced dedifferentiation and apoptosis by modulating p38 kin ase, ERK and PKC via a
PI3-kinase pathway -Previous studies by our group demonstrate that NO induces activation of p38 kinase, leading to apoptosis and activation of ERK-1/-2, which in turn causes chondrocyte dedifferentiation (9) . NO also inhibits PKCζ as a result of p38 kinase activation and PKCα that is independent of ERK or p38 kinase signaling (10). We therefore investigated IGF-1 modulation of apoptosis and dedifferentiation, focus ing on the role of NO-induced activation of ERK-1/-2 and p38 kinase and inhibition of PKCα and ζ. Consistent with previous findings (9) , NO triggered ERK-1/-2 and p38 kinase activation, as confirmed by Western blot analysis and an in vitro kinase assay respectively (Fig. 9A) . IGF-1 treatment prior to NO production blocked NO-induced activation of ERK -1/-2 and p38 kinase. Effects of IGF-1 were abolished by the PI3-kinase inhibitor, LY294002
( Fig. 9 A) . Direct production of NO additionally led to decreased protein levels and activities of PKCα and ζ.
Inhibition of PKCα and ζ by NO was blocked by IGF-1 (Fig. 9B) . Moreover, treatment with LY294002
abolished IGF-1 effects on PKCα and ζ (Fig. 9C) . The significance of IGF-1 modulation of ERK, p38 kinase, and PKCα and ζ was examined by inhibiting individual kinases in the absence of the growth factor. As shown in Fig. 9D , inhibition of NO-induced ERK activation with PD98059 enhanced apoptosis with inhibitory effects on dedifferentiation, whereas blockage of p38 kinase with SB203580 suppressed apoptosis with stimulatory by guest on October 1, 2017
http://www.jbc.org/ Downloaded from effects on dedifferentiation. NO-induced apoptosis and dedifferentiation were additionally blocked upon ectopic expression of PKCα or ζ (Fig. 9D) . The above data indicate that blockage of NO-induced ERK -1/-2 and p38 kinase activation and PKCα and ζ inhibition by IGF-1 via the PI3-kinase pathway is responsible for IGF-1-induced inhibition of apoptosis and dedifferentiation of articular chondrocytes.
In articular chondrocytes, activation of p38 kinase and inhibition of PKCα and ζ by NO induces activation of NF-κB and caspase-3, and accumulation of p53 , resulting in apoptotic cell death (11, 12) . We examined the role of IGF-1 and PI3-kinase in apoptotic signaling. Consistent with the inhibition of NO-induced upstream apoptotic signals, such as activation of p38 kinase and inhibition of PKCα and ζ, IGF-1 blocked NO-induced degradation of inhibitory κB (I-κB) (Fig. 10A) , activation of NF-κB ( Fig. 10B ) and caspase-3 (Figs. 10A and 10C), and expression of pro-apoptotic Bax (Fig. 10 A) . Furthermore , the effects of IGF-1 on apoptotic signaling were blocked by LY294002. The results collectively indicate that IGF-1 block s NO-induced apoptosis by inhibiting apoptotic signaling through the PI3-kinase pathway. 
